Dr. Reddy's Laboratories Ltd Company Profile (NYSE:RDY)

About Dr. Reddy's Laboratories Ltd

Dr. ReddyDr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company's business of manufacturing and marketing active pharmaceutical ingredients and intermediates (API) or bulk drugs. Proprietary Products segment focuses on the research, development and manufacture of differentiated formulations and new chemical entities. These products fall within the dermatology and neurology therapeutic areas, and are marketed and sold through its subsidiary, Promius Pharma, LLC.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: RDY
  • CUSIP:
Key Metrics:
  • Previous Close: $43.59
  • 50 Day Moving Average: $44.73
  • 200 Day Moving Average: $45.94
  • 52-Week Range: $165,726,000.00 - $41.60
  • Trailing P/E Ratio: 50.72
  • Foreward P/E Ratio: 21.20
  • P/E Growth: 1.93
  • Market Cap: $7.20B
  • Outstanding Shares: 165,726,000
  • Beta: 0.53
Profitability:
  • Net Margins: 6.69%
  • Return on Equity: 8.00%
  • Return on Assets: 4.59%
Debt:
  • Debt-to-Equity Ratio: 0.09%
  • Current Ratio: 1.12%
  • Quick Ratio: 0.80%
Additional Links:
Companies Related to Dr. Reddy's Laboratories Ltd:

Analyst Ratings

Consensus Ratings for Dr. Reddy's Laboratories Ltd (NYSE:RDY) (?)
Ratings Breakdown: 3 Sell Ratings, 1 Hold Rating
Consensus Rating:Sell (Score: 1.25)
Consensus Price Target: $41.90 (3.61% downside)

Analysts' Ratings History for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Show:
DateFirmActionRatingPrice TargetDetails
7/27/2016HSBC Holdings plcDowngradeHold -> ReduceView Rating Details
7/27/2016Jefferies Group LLCDowngradeHold -> Underperform$45.00 -> $41.90View Rating Details
7/26/2016Credit Suisse GroupDowngradeNeutral -> UnderperformView Rating Details
5/2/2016Goldman Sachs Group, Inc. (The)Initiated CoverageNeutralView Rating Details
12/2/2015Deutsche Bank AGInitiated CoverageSellView Rating Details
11/10/2015Citigroup Inc.DowngradeBuy -> NeutralView Rating Details
11/6/2015Barclays PLCDowngradeOverweight -> Equal WeightView Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2016Q117$0.00$557.00 million$479.00 millionViewListenView Earnings Details
5/12/2016Q416$0.07$2.41 billion$567.00 billionViewListenView Earnings Details
2/9/2016Q316$0.51$2.48 million$599.00 millionViewN/AView Earnings Details
10/29/2015Q116$0.65$2.54 billionViewListenView Earnings Details
5/12/2015Q415$0.49$559.00 million$621.00 millionViewListenView Earnings Details
1/29/2015Q315$0.53$561.00 million$610.00 millionViewN/AView Earnings Details
7/30/2014Q115$0.54$474.00 million$486.00 millionViewN/AView Earnings Details
5/13/2014Q414$0.52$0.47$557.00 million$580.00 millionViewN/AView Earnings Details
2/11/2014Q314$0.45$0.59$558.20 million$571.00 millionViewN/AView Earnings Details
10/31/2013Q214$0.46$0.65$561.00 million$537.00 millionViewN/AView Earnings Details
7/30/2013Q413$0.43$0.40$551.40 million$478.00 millionViewN/AView Earnings Details
5/14/2013$0.60ViewN/AView Earnings Details
2/14/2013Q313$0.40$505.00 million$522.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Current Year EPS Consensus Estimate: $1.20 EPS
Next Year EPS Consensus Estimate: $2.05 EPS

Dividends

Current Dividend Information for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
Annual Dividend:$0.28
Dividend Yield:0.64%
Dividend Growth:7.40% (3 Year Average)
Payout Ratio:32.18% (Based on Trailing 12 Months of Earnings)
23.33% (Based on Current Year Consensus EPS Estimate)
13.66% (Based on Next Year Consensus EPS Estimate)

Dividend History for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/6/2016Annual$0.287/14/20167/18/20167/18/2016
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Dr. Reddy's Laboratories Ltd (NYSE:RDY)
DateHeadline
News IconDr Reddys Labs - Clarification (NYSE:RDY)
www.moneycontrol.com - February 17 at 7:58 PM
News IconDr. Reddy's Laboratories announces US District Court's opinion relating to patent infringement (NYSE:RDY)
www.equitybulls.com - February 17 at 7:57 PM
News IconNYSE:RDY Investor News: Investigation over possible Securities Laws Violations by Dr.Reddy’s Laboratories Ltd (NYSE:RDY)
www.groundreport.com - February 17 at 7:57 PM
News IconDr.Reddy’s Laboratories Ltd (ADR) (NYSE:RDY) Investor Investigation over possible Violations of Securities Laws (NYSE:RDY)
www.satprnews.com - February 16 at 7:08 PM
us.rd.yahoo.com logo7:32 am Dr. Reddy's announces Court patent ruling (NYSE:RDY)
us.rd.yahoo.com - February 16 at 7:08 PM
News IconDr Reddy's, Aurobindo Pharma Recall Some Drugs From US Market, Says Regulator (NYSE:RDY)
profit.ndtv.com - February 15 at 5:32 AM
News IconDr Reddy's, Aurobindo recall drugs from US market (NYSE:RDY)
www.thehansindia.com - February 15 at 5:32 AM
News IconHow Often Does Dr. Reddy's Laboratories Limited (RDY) Beat Earnings Estimates? - Post Analyst (NYSE:RDY)
postanalyst.com - February 15 at 12:32 AM
News IconDr. Reddy's Laboratories - 3QFY17 Result Update - Long-term Fundamentals Remain Intact; Headwinds to Persist in the Near-term - Reliance Securities (NYSE:RDY)
www.equitybulls.com - February 13 at 12:22 AM
News IconDr Reddy's launches generic drugs in France; expands operations in Europe (NYSE:RDY)
health.economictimes.indiatimes.com - February 10 at 10:22 PM
finance.yahoo.com logoDr. Reddy's Expands Commercial Operations in Europe (NYSE:RDY)
finance.yahoo.com - February 8 at 10:22 PM
livemint.com logoDr. Reddy's Laboratories slips on reporting 16% fall in Q3 consolidated net profit (NYSE:RDY)
money.livemint.com - February 7 at 10:53 PM
capitalcube.com logoDr. Reddy’s Laboratories Ltd. :RDY-US: Earnings Analysis: Q3, 2017 By the Numbers : February 7, 2017 (NYSE:RDY)
us.rd.yahoo.com - February 7 at 10:53 PM
News IconDr Reddys Laboratories Ltd's Q3FY17 consolidated net profit declines 16.55% yoy to Rs.483.40 crore : Beats Estimates (NYSE:RDY)
www.indiainfoline.com - February 7 at 12:37 AM
nasdaq.com logoDr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q3 - Nasdaq (NYSE:RDY)
www.nasdaq.com - February 6 at 7:37 PM
News IconNeutral Dr. Reddy's Laboratories with a target of Rs 3400 – UBS (NYSE:RDY)
economictimes.indiatimes.com - February 6 at 8:48 AM
zacks.com logoDr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q3 (NYSE:RDY)
www.zacks.com - February 6 at 8:48 AM
finance.yahoo.com logo3:06 am Dr. Reddy's beats bottom line estimates, misses on top (NYSE:RDY)
finance.yahoo.com - February 6 at 8:48 AM
businesswire.com logoDr. Reddy's Q3 and 9M FY17 Financial Results | Business Wire - Business Wire (press release) (NYSE:RDY)
www.businesswire.com - February 5 at 8:24 AM
reuters.com logoIndia Dr. Reddy's Dec quarter net profit fell 16 pct (NYSE:RDY)
www.reuters.com - February 5 at 12:34 AM
us.rd.yahoo.com logoDr. Reddy's December quarter net profit fell 16 pct (NYSE:RDY)
us.rd.yahoo.com - February 4 at 7:34 PM
finance.yahoo.com logoDr. Reddy’s Q3 and 9M FY17 Financial Results (NYSE:RDY)
au.finance.yahoo.com - February 4 at 7:34 PM
nasdaq.com logoDr. Reddy's Laboratories (RDY) Shares Cross Above 200 DMA (NYSE:RDY)
www.nasdaq.com - February 2 at 11:24 PM
live-pr.com logoDr. Reddy's Laboratories Limited - Strategy, SWOT and Corporate Finance Report - New Report Available (NYSE:RDY)
www.live-pr.com - February 1 at 10:51 PM
News IconInvestigation for Investors in Shares of Dr.Reddy’s Laboratories Ltd (ADR) (NYSE:RDY) Announced (NYSE:RDY)
www.satprnews.com - February 1 at 10:51 PM
finance.yahoo.com logoBlog Coverage Teva Announced FDA Approval for Two Asthma Products; Plans to Appeal Court Decision on COPAXONE (NYSE:RDY)
finance.yahoo.com - January 31 at 9:48 PM
insidermonkey.com logoTop 10 Pharmaceutical Companies In India (NYSE:RDY)
www.insidermonkey.com - January 31 at 9:48 PM
investornewswire.com logoDr. Reddy's Laboratories Ltd (NYSE:RDY) Strong Sell Recommendations At 0 - Investor Newswire (NYSE:RDY)
www.investornewswire.com - January 31 at 1:13 AM
News IconAre Insiders Bumping Up Their Positions in Dr. Reddy's Laboratories Limited (NYSE:RDY) - Wall Street Beacon (NYSE:RDY)
wsbeacon.com - January 31 at 1:13 AM
News IconChecking the Charts for Dr. Reddy`s Laboratories Ltd. (RDY) - Rives Journal (NYSE:RDY)
rivesjournal.com - January 30 at 8:02 AM
News IconHold Dr Reddy’s Laboratories: Prakash Gaba (NYSE:RDY)
www.moneycontrol.com - January 28 at 6:05 AM
reuters.com logoBRIEF-Dr.Reddy's Labs says co not served with legal papers in matter as in Mezzion's press release (NYSE:RDY)
www.reuters.com - January 28 at 6:05 AM
seekingalpha.com logoFDA rejection of Mezzion's marketing application for ED candidate udenafil prompts lawsuit against supplier Dr. Reddy's Labs (NYSE:RDY)
seekingalpha.com - January 24 at 9:05 PM
4-traders.com logoInvestigation of Dr. Reddy’s Laboratories Announced by Holzer & Holzer (NYSE:RDY)
www.4-traders.com - January 24 at 9:05 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Dr. Reddy's Laboratories Limited (RDY) (NYSE:RDY)
finance.yahoo.com - January 24 at 9:05 PM
finance.yahoo.com logoINVESTOR ALERT: Investigation of Dr. Reddy’s Laboratories Announced by Holzer & Holzer (NYSE:RDY)
finance.yahoo.com - January 24 at 8:17 AM
News IconAre Insiders Filling Their Own Pockets With Shares? Insider Update on Dr. Reddy's Laboratories Limited (NYSE:RDY) - Wall Street Beacon (NYSE:RDY)
wsbeacon.com - January 23 at 7:48 PM
benzinga.com logoDr. Reddy's to Release Q3 FY17 Results on... (NYSE:RDY)
www.benzinga.com - January 23 at 9:10 AM
finance.yahoo.com logoDr. Reddy's to Release Q3 FY17 Results on Feb 4, 2017 (NYSE:RDY)
au.finance.yahoo.com - January 23 at 9:10 AM
News IconDr. Reddy's Laboratories Ltd (NYSE:RDY) Under Analyst Spotlight - UK Market News (NYSE:RDY)
www.ukmarketnews.co.uk - January 23 at 12:16 AM
News IconDr. Reddy's Laboratories Ltd DRREDDY Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NYSE:RDY)
www.bioportfolio.com - January 20 at 10:12 PM
News IconTracking Corporate Insiders: What Are They Doing With Dr. Reddy's Laboratories Limited (NYSE:RDY) - Wall Street Beacon (NYSE:RDY)
wsbeacon.com - January 16 at 1:20 PM
livemint.com logoUSFDA to re-audit Dr. Reddy’s Laboratories manufacturing facilities (NYSE:RDY)
www.livemint.com - January 12 at 1:17 AM
streetinsider.com logoForm 6-K DR REDDYS LABORATORIES For: Nov 30 (NYSE:RDY)
www.streetinsider.com - January 10 at 9:16 PM
seekingalpha.com logoDr. Reddy's launches two new generics in U.S. (NYSE:RDY)
seekingalpha.com - January 10 at 9:16 PM
investornewswire.com logoDr. Reddy's Laboratories Ltd (NYSE:RDY) Strong Sell Recommendations At {RATING_CNT_STRONG_SELLS:378}} - Investor Newswire (NYSE:RDY)
www.investornewswire.com - January 10 at 1:18 AM
finance.yahoo.com logoDr. Reddy's Laboratories Limited to Present at the J.P. Morgan 35th Annual Healthcare Conference - Yahoo Finance (NYSE:RDY)
finance.yahoo.com - January 10 at 1:18 AM
businesswire.com logoDr. Reddy's Laboratories Limited to Present at the J.P. Morgan 35 th Annual Healthcare Conference (NYSE:RDY)
www.businesswire.com - January 9 at 8:11 PM
finance.yahoo.com logoDr. Reddy's Laboratories Limited to Present at the J.P. Morgan 35th Annual Healthcare Conference (NYSE:RDY)
au.finance.yahoo.com - January 9 at 8:11 PM
News IconDr Reddy’s helps women get back on the career beat (NYSE:RDY)
www.thehindubusinessline.com - January 8 at 12:05 AM

Social

What is Dr. Reddy's Laboratories Ltd's stock symbol?

Dr. Reddy's Laboratories Ltd trades on the New York Stock Exchange (NYSE) under the ticker symbol "RDY."

How often does Dr. Reddy's Laboratories Ltd pay dividends? What is the dividend yield for Dr. Reddy's Laboratories Ltd?

Dr. Reddy's Laboratories Ltd announced an annual dividend on Monday, June 6th. Investors of record on Monday, July 18th will be paid a dividend of $0.277 per share on Monday, July 18th. The ex-dividend date of this dividend is Thursday, July 14th.

Where is Dr. Reddy's Laboratories Ltd's stock going? Where will Dr. Reddy's Laboratories Ltd's stock price be in 2017?

4 analysts have issued 1 year target prices for Dr. Reddy's Laboratories Ltd's stock. Their forecasts range from $41.90 to $41.90. On average, they anticipate Dr. Reddy's Laboratories Ltd's share price to reach $41.90 in the next twelve months.

Who owns Dr. Reddy's Laboratories Ltd stock?

Dr. Reddy's Laboratories Ltd's stock is owned by many different of institutional and retail investors. Top institutional investors include AQR Capital Management LLC (1.38%), Dimensional Fund Advisors LP (0.39%), State Street Corp (0.32%), DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main (0.19%), Axiom International Investors LLC DE (0.15%) and Aviva PLC (0.05%).

Who sold Dr. Reddy's Laboratories Ltd stock? Who is selling Dr. Reddy's Laboratories Ltd stock?

Dr. Reddy's Laboratories Ltd's stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, FIL Ltd, Commerzbank Aktiengesellschaft FI, State Street Corp, Guggenheim Capital LLC, Dimensional Fund Advisors LP, NINE MASTS CAPITAL Ltd and Hanson & Doremus Investment Management.

Who bought Dr. Reddy's Laboratories Ltd stock? Who is buying Dr. Reddy's Laboratories Ltd stock?

Dr. Reddy's Laboratories Ltd's stock was bought by a variety of institutional investors in the last quarter, including DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main, Portland Hill Capital LLP, Russell Investments Group Ltd., Oxford Asset Management, Axiom International Investors LLC DE, Pacad Investment Ltd., Bayesian Capital Management LP and Allianz Asset Management AG.

How do I buy Dr. Reddy's Laboratories Ltd stock?

Shares of Dr. Reddy's Laboratories Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Dr. Reddy's Laboratories Ltd stock cost?

One share of Dr. Reddy's Laboratories Ltd stock can currently be purchased for approximately $43.47.

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Dr. Reddy`s Laboratories Ltd (NYSE:RDY)

Earnings History Chart

Earnings by Quarter for Dr. Reddy`s Laboratories Ltd (NYSE:RDY)

Dividend History Chart

Dividend Payments by Quarter for Dr. Reddy`s Laboratories Ltd (NYSE:RDY)

Last Updated on 2/20/2017 by MarketBeat.com Staff